Literature DB >> 8719369

Quality of life, sexual functioning and sex role identity after surgical orchidectomy in patients with prostatic cancer.

M D Lucas1, S C Strijdom, M Berk, G A Hart.   

Abstract

Surgical orchidectomy is a simple procedure with few physical side effects, low mortality, and cost effectiveness. Nevertheless, there can be negative sequelae such as sexual dysfunction, impaired quality of life, and poor body image. Although it is a frequent treatment approach for prostate cancer, it is not clear whether these sequelae are problematic for this patient group. It is possible that relief from painful metastases and the prolongation of life outweigh these negative factors. The present study investigated quality of life, sex-role identity, and sexual function in 15 patients with stage D prostate cancer, before and after surgery. Orchidectomy did not appear to affect quality of life, or sex-role identity. However, loss of sexual function did present as an area of concern. It was noted that 55% of premorbidly sexually active patients found this loss disturbing. These patients, premorbidly, appeared to have higher sex-role stereotypy.

Entities:  

Mesh:

Year:  1995        PMID: 8719369     DOI: 10.3109/00365599509180033

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  7 in total

1.  Individualized strategy for dosing luteinizing hormone-releasing hormone agonists for androgen-independent prostate cancer: identification of outcomes and costs.

Authors:  Jennifer A Wagmiller; Jennifer J Griggs; Andrew W Dick; Deepak M Sahasrabudhe
Journal:  J Oncol Pract       Date:  2006-03       Impact factor: 3.840

Review 2.  Pharmacoeconomics of available treatment options for metastatic prostate cancer.

Authors:  Steven B Zeliadt; David F Penson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Global outcomes and lessons learned in the management of Fournier's gangrene from high-volume centres: findings from a literature review over the last two decades.

Authors:  Daniel Bowen; Patrick Juliebø-Jones; B K Somani
Journal:  World J Urol       Date:  2022-09-04       Impact factor: 3.661

Review 4.  Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment.

Authors:  Suzanne K Chambers; Eric Chung; Gary Wittert; Melissa K Hyde
Journal:  Transl Androl Urol       Date:  2017-02

5.  Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer.

Authors:  Hala T Borno; Daphne Y Lichtensztajn; Scarlett L Gomez; Nynikka R Palmer; Charles J Ryan
Journal:  Cancer       Date:  2018-11-16       Impact factor: 6.921

Review 6.  Current state of prostate cancer treatment in Jamaica.

Authors:  Belinda F Morrison; William D Aiken; Richard Mayhew
Journal:  Ecancermedicalscience       Date:  2014-08-28

Review 7.  The current state of prostate cancer treatment in Trinidad and Tobago.

Authors:  Satyendra Persaud; Maliza Persaud; Lester Goetz; Dylan Narinesingh
Journal:  Ecancermedicalscience       Date:  2018-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.